IRIS
RIGAMONTI, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.957
NA - Nord America 1.322
AS - Asia 551
SA - Sud America 22
AF - Africa 18
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.881
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.282
IE - Irlanda 744
IT - Italia 408
SE - Svezia 278
DE - Germania 176
UA - Ucraina 164
SG - Singapore 150
HK - Hong Kong 117
IN - India 85
CN - Cina 56
FI - Finlandia 49
FR - Francia 49
VN - Vietnam 39
CA - Canada 33
TR - Turchia 25
GB - Regno Unito 23
IR - Iran 23
CZ - Repubblica Ceca 20
PK - Pakistan 12
NL - Olanda 10
KR - Corea 9
AU - Australia 8
PE - Perù 8
CH - Svizzera 7
MY - Malesia 7
BE - Belgio 6
JP - Giappone 6
KE - Kenya 6
BR - Brasile 5
TH - Thailandia 5
CO - Colombia 4
EG - Egitto 4
ES - Italia 4
MO - Macao, regione amministrativa speciale della Cina 4
MX - Messico 4
PH - Filippine 4
ZA - Sudafrica 4
CL - Cile 3
EU - Europa 3
GR - Grecia 3
IL - Israele 3
LT - Lituania 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CU - Cuba 2
LY - Libia 2
NO - Norvegia 2
RS - Serbia 2
RU - Federazione Russa 2
TW - Taiwan 2
BD - Bangladesh 1
KH - Cambogia 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
PL - Polonia 1
PR - Porto Rico 1
PT - Portogallo 1
SN - Senegal 1
Totale 3.881
Salva come PNG Salva come JPEG
Città #
Dublin 732
Jacksonville 308
Singapore 107
Hong Kong 104
Chandler 99
Lawrence 82
Princeton 82
Wilmington 71
San Mateo 69
Dearborn 54
Piemonte 49
Dong Ket 36
Novara 33
Ashburn 29
Bremen 27
Turin 27
Ann Arbor 25
Vercelli 25
Milan 24
Andover 21
Beijing 20
Boardman 20
Brno 18
Helsinki 18
Norwalk 16
Munich 15
Chennai 14
Monmouth Junction 13
Toronto 12
Frankfurt am Main 10
Kocaeli 10
West Jordan 10
Ardabil 9
Augusta 9
Fairfield 8
Istanbul 8
Montreal 8
New York 8
Rome 8
Santa Clara 8
Mülheim 7
Philadelphia 7
Royal Leamington Spa 7
Sham Shui Po 7
Woodbridge 7
Alessandria 6
Brussels 6
Leawood 6
Nairobi 6
Nanjing 6
Palermo 6
Paris 6
Bangkok 5
Chimbote 5
Hefei 5
Los Angeles 5
Naples 5
Seattle 5
Strasbourg 5
Vancouver 5
Vedano Olona 5
Zurich 5
Berlin 4
Bologna 4
Brescia 4
Cassano Magnago 4
Grafing 4
Johannesburg 4
Macao 4
Mumbai 4
Redwood City 4
Senigallia 4
Sydney 4
Tehran 4
Zanjan 4
Athens 3
Bien Hoa 3
Busalla 3
Busanjin-gu 3
Charleston 3
Costa Masnaga 3
Gorgonzola 3
Goyang-si 3
Greenville 3
Guelph 3
Houston 3
Ipoh 3
Lima 3
London 3
Padova 3
Pioltello 3
Rennes 3
San Diego 3
Sialkot 3
Temuco 3
Amsterdam 2
Ankara 2
Appiano Gentile 2
Arcene 2
Aubervilliers 2
Totale 2.495
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 243
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 145
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 104
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 95
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 91
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 80
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 77
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 73
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 69
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 69
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 68
Chronic hepatitis C is mild in menstruating women 66
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 58
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases 57
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 55
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 55
Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method 54
Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C 53
Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study 52
Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome 51
Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids 51
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 50
CYP2E1 autoantibodies in liver diseases 50
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 50
Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C 49
Giant liver fibrous tumours metastatic from atypical recurrent meningeal neoplasia 49
Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019 49
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 48
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 47
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 47
Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C 47
Outcome of COVID-19 in Patients with Autoimmune Hepatitis: an International Multi-Centre Study 45
Coronavirus Disease 2019 (COVID‐19) in autoimmune hepatitis: a lesson from immunosuppressed patients 44
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 44
Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients 43
Elastography in Liver-Transplanted Patients 41
Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes 41
Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C 40
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 40
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 38
Iron, hepatic stellate cells and fibrosis in chronic hepatitis C 38
Gender and liver fibrosis in chronic hepatitis: the role of iron status 37
Authors’ response re: “The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs” 37
Severe thombocytopenia and clinical bleeding associated with rituximab infusion in a lynphoma patient with massive splenomegaly without leukemic invasion 36
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 36
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: Results from a 29-year cohort study 36
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 35
Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease 35
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis 32
Adequate vs. deep response to UDCA in PBC: To what extent and under what conditions is normal ALP level associated with complication-free survival gain? 31
High prevalence of acute onset autoimmune hepatitis in males: A real-life cohort from Northern Italy 30
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 30
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 29
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 28
Hepatocellular carcinoma after direct-acting antiviral agents: Can liver stiffness kinetics help identify patients at lower risk? 28
LIVER BIOPSY TECHNIQUES: AUTOMATED ASPIRATION NEEDLES PROVIDE ADEQUATE TISSUE SAMPLES 27
Can protocol liver biopsy be avoided to evaluate post-transplant hepatitis C recurrence? Transient elastography makes it possible 27
Spleen Stiffness Measured by Transient Elastography Accurately Predicts Esophageal Varices in Liver Cirrhosis 27
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C 27
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury 27
Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach 26
Diagnosis of cirrhosis by transient elastography: what is hidden behind misleading results 26
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 26
Long term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years 26
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 26
ERCP and short-term stent-trial in patients with anastomotic biliary stricture following liver transplantation 26
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 26
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges 26
Transjugular liver biopsy: The Tru-cut needle might be better for stiffer livers 26
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease 25
Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation 24
Do not trivialize the Fibroscan® examination, value its accuracy 24
Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsy 24
Severe thrombocytopenia and clinical bleeding associated with rituximab infusion in a lymphoma patient with massive splenomegaly without leukemic invasion 24
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy 24
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 24
SURVIVAL FOLLOWING THE DEVELOPMENT OF ASCITES AND/OR PERIPHERAL OEDEMA IN PRIMARY BILIARY CIRRHOSIS: A STAGED PROGNOSTIC MODEL 24
Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation 24
Transient elastography in the assessment of liver fibrosis in adult thalassemia patients 24
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 23
Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study 23
Might rapid virological response be used as a stopping rule in liver transplant recipients treated with pegylated interferon plus ribavirin? 23
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipients 23
Transient elastography 23
Liver stiffness, a non-invasive marker of liver disease: a core study group report 23
Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation 22
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 22
Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis 21
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 20
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation 19
Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C 18
Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years 17
Emerging Issues in the Immunopathogenesis, Diagnosis and Clinical Management of Primary Biliary Cirrhosis Associated with Systemic Sclerosis 17
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 17
The evolving landscape of autoimmune hepatitis: an ambispective cohort study 16
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 15
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 14
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 14
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis 13
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis 11
Totale 4.030
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.476
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020273 0 0 0 0 0 37 49 14 31 64 26 52
2020/2021562 65 0 73 0 88 21 71 11 79 31 81 42
2021/2022613 17 47 79 44 38 17 43 20 60 37 82 129
2022/20231.418 155 84 70 19 69 87 56 60 718 19 48 33
2023/2024767 38 61 43 23 107 38 142 60 28 42 54 131
2024/2025308 30 25 110 41 56 46 0 0 0 0 0 0
Totale 4.058